Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab, AstraZeneca’s benralizumab, Amgen Inc ...
BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...
The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...
Herbal Medicinal Products Market. The global herbal medicinal products market is experiencing significant growth, with total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback